CTI BioPharma

1 follower

‌

CTI BioPharma (NASDAQ: CTIC) is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers.

Industries

Headquarters

Stage

Employees

Links

Org chart

View full screen

Adam R. Craig

President, CEO & Interim Chief Medical Officer

Adam R. Craig

Collapse

David H. Kirske

EVP, CFO

James K. Fong

SVP, Commercial Operations

John P. Volpone

SVP, Strategic Operations

Shantha Tyavanagimatt

Senior Vice President, Global Pharmaceutical Operations (cmc) And Early Development

Teams

View all

Board of Directors

5 members

CEO and Executive Team

2 members

Leadership Team

2 members

Discover similar companies

Coherus BioSciences

5 followers

BioMarin Pharmaceutical

20 followers

Adaptive Biotechnologies

11 followers

Eikon Therapeutics

1 follower

Dragonfly Therapeutics

1 follower